Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted Therapy

NCT07833761 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07833761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07833761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted Therapy
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 31, 2030
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder, borderline personality pathology, depressive symptoms, emotion dysregulation, suicidal ideation